C

Crescent Biopharma

Clinical-stage biotech developing solid-tumor therapies

Executive Director/Vice President – Medical Lead

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeWaltham, MA, USAIn-person

About the Job

Requirements

  • An MD or equivalent degree with clinical training in oncology, immuno-oncology, or a related medical specialty.
  • At least 7 years of experience in the life sciences industry, including substantial oncology-focused medical oversight responsibilities.
  • Experience in a biotech environment with antibody-drug conjugates or other targeted biologic therapies is preferred.
  • Demonstrated experience in clinical drug development, including trial design, execution, and data interpretation in biotech or biopharma settings.
  • A track record of authoring clinical trial documents, including protocols, investigator brochures, and clinical study reports, and contributing to regulatory submissions, including INDs, CTAs, amendments, and briefing books.
  • Knowledge of regulatory agency guidelines, including FDA, EMA, and ICH-GCP, and experience supporting GCP audits or regulatory inspections related to clinical trial conduct.
  • Ability to synthesize complex data into clear, actionable insights.
  • Leadership, cross-functional collaboration, and relationship-building skills with internal and external stakeholders.
  • Self-motivation, attention to detail, adaptability, and a proactive approach to problem-solving and execution in a fast-paced environment.

Responsibilities

  • Develop and implement the clinical development strategy and target product profile for assigned programs.
  • Lead the design, initiation, and execution of early-phase clinical studies, including protocol and investigator brochure development, endpoint selection, and dose-escalation strategies.
  • Serve as the medical monitor of ongoing studies, ensuring subject safety, high-quality data collection, and adherence to GCP and regulatory standards.
  • Interpret and communicate emerging data across internal and external stakeholders, contributing to clinical study reports, publications, and presentations.
  • Contribute clinical content for regulatory submissions, including IND/CTA filings, amendments, and briefing documents, and support interactions with health authorities.
  • Partner with colleagues in nonclinical, translational, clinical operations, regulatory, program management, and CMC to align program objectives and milestones.
  • Build and maintain relationships with key opinion leaders, clinical investigators, and partners to inform study design and program direction.

About the Company

Crescent Biopharma

Clinical-stage biotech developing solid-tumor therapies

Crescent Biopharma develops oncology therapies for solid tumors, led by CR-001, a tetravalent bispecific antibody that blocks PD-1 and VEGF to boost anti-tumor immunity while inhibiting tumor blood vessel growth. CR-001 sits in a global Phase 1/2 ASCEND trial, and the pipeline also includes CR-002, an anti-PD-L1 antibody-drug conjugate, and CR-003, an ITGB6-targeted ADC. The company differentiates itself by combining immune checkpoint blockade with VEGF inhibition and other targeted modalities to build an immuno-oncology backbone for solid tumors, supported by strategic partnerships and substantial private placements. Crescent’s goal is to advance multi-agent regimens toward regulatory approval and commercial development for patients with solid tumors.

Company size
51-200
Company stage
IPO
Headquarters
Waltham, MA
Founded
2003

Recently Posted Jobs

Explore more opportunities at Crescent Biopharma

See more jobs